Arceo-Mendoza RM, Camacho P (2015) Prediction of fracture risk in patients with osteoporosis a brief review. Womens Health (Lond) 11(4):477–482. https://doi.org/10.2217/whe.15.14. (quiz 483)

Article  CAS  PubMed  Google Scholar 

Dobbs MB, Buckwalter J, Saltzman C (1999) Osteoporosis: the increasing role of the orthopaedist. Iowa Orthop J 19:43–52

CAS  PubMed  PubMed Central  Google Scholar 

Hemmati E, Mirghafourvand M, Mobasseri M, Shakouri SK, Mikaeli P, Farshbaf-Khalili A (2021) Prevalence of primary osteoporosis and low bone mass in postmenopausal women and related risk factors. J Educ Health Promot 10:204. https://doi.org/10.4103/jehp.jehp_945_20

Article  PubMed  PubMed Central  Google Scholar 

Sözen T, Özışık L, Başaran NÇ (2017) An overview and management of osteoporosis. Eur J Rheumatol 4(1):46–56. https://doi.org/10.5152/eurjrheum.2016.048

Article  PubMed  Google Scholar 

Reginster JY, Burlet N (2006) Osteoporosis a still increasing prevalence. Bone 38(2 Suppl 1):S4–S9. https://doi.org/10.1016/j.bone.2005.11.024

Article  PubMed  Google Scholar 

National OP foundation (2003) Physician’s guide to prevention and treatment of OP. Washington (DC): National OP foundation, p 1

Karaguzel G, Holick MF (2010) Diagnosis and treatment of osteopenia. Rev Endocr Metab Disord 11(4):237–251. https://doi.org/10.1007/s11154-010-9154-0

Article  CAS  PubMed  Google Scholar 

LeBoff MS et al (2022) The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 33(10):2049–2102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holick MF (2007) Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 24(12):1017–1029. https://doi.org/10.2165/00002512-200724120-00005

Lee DS, Lee SS, Kim SW (2022) ionized Cal/MagTM complex as an alternative supplement for enhancing bone mineral density Preliminary Results from Primary Care Centers Dongho Shin. Oriental J Food Nutr 35(5):295–301

Google Scholar 

Reid IR, Bolland MJ (2019) Controversies in medicine: the role of calcium and vitamin D supplements in adults. Med J Aust 211(10):468–473. https://doi.org/10.5694/mja2.50393

Article  PubMed  Google Scholar 

Zhao JG, Zeng XT, Wang J, Liu L (2017) Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: A systematic review and meta-analysis. JAMA 318(24):2466–2482. https://doi.org/10.1001/jama.2017.19344

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai L, Li H, Wei Y (1998) Effect of Yangxue bushen tablet on ovarian function in animal model of Yang deficiency. Zhongguo Zhong Xi Yi Jie He Za Zhi 18(10):620–622

CAS  PubMed  Google Scholar 

Qin L, Zhang G, Hung WY, Shi Y, Leung K, Yeung HY, Leung P (2005) Phytoestrogen-rich herb formula “XLGB prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats.” J Bone Miner Metab 23(Suppl):55–61. https://doi.org/10.1007/BF03026324

Article  PubMed  Google Scholar 

Dong YF (2004) Clinical observation on treatment of OP with Epimedium and other Chinese medicines. Chin Herb Med 27(8):620–622

Google Scholar 

Wang LX, Li W (2010) Observation on therapeutic effect of 40 cases of OP treated by Chinese medicine. Xinjiang J Trad Chin Med 28(5):16–18

MathSciNet  CAS  Google Scholar 

Zeng X, Tang Q, Wang LJ, Tan T, Shi L, Niu XD (2017) Clinical efficacy of Epimedium in the treatment of OP. Chin J Clin Ratio Drug Use 10(3):101–102

Google Scholar 

Park TS (2002) Effects of herbal medicine prescription on calcium and iron bioavailability (00-PJ9-PG3–22000–0002). Oriental Ministry of Health and Welfare, Sejong, p 82–86

Zhu HM et al (2012) The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis. Osteoporos Int 23(4):1317–1327. https://doi.org/10.1007/s00198-011-1577-2

Article  MathSciNet  CAS  PubMed  Google Scholar 

Lu-wen S, Hui Z, Zhi-ming XIA, Yi-you F (2015) Therapeutic evaluation of He wei Jie gu Decoction on femoral intertrochanteric fracture after internal fixation in elderly: a randomized controlled trial. China J Orthop Traumatol 28(5):417–421

Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) PRISMA Group Preferred reporting items for systematic reviews and meta- analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097

Article  PubMed  PubMed Central  Google Scholar 

Higgins JPT (2011) Green S Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration. http://www.cochrane-handbook.org. Accessed 20 Nov 2021

World Health Organization (2019) International Statistical Classification of Diseases and Related Health Problems, 11th edn. https://icd.who.int/

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12. https://doi.org/10.1016/0197-2456(95)00134-4

Article  CAS  PubMed  Google Scholar 

Schünemann HJ, Oxman AD, Brozek J et al (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 24(336):7654 https://doi.org/10.1136/bmj.a139

Google Scholar 

Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, McGinn T, Hayden J, Williams K, Shea B, Wolff R, Kujpers T, Perel P, Vandvik PO, Glasziou P, Schunemann H, Guyatt G (2015) Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ 16(350):h870. https://doi.org/10.1136/bmj.h870

Article  Google Scholar 

Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, Norris S, Vist G, Dahm P, Shukla VK, Higgins J, Falck-Ytter Y, Schünemann HJ (2011) GRADE Working Group GRADE guidelines 7: Rating the quality of evidence–inconsistency. J Clin Epidemiol. 64(12):1294–302. https://doi.org/10.1016/j.jclinepi.2011.03.017

Article  PubMed  Google Scholar 

Guyatt GH, Oxman AD, Kunz R, et al (2011) GRADE guidelines 8 Rating the quality of evidence—indirectness. J Clin Epidemiol 64 12 1303–1310 https://doi.org/10.1016/j.jclinepi.2011.04.014

Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW Jr, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Schünemann HJ (2021) GRADE guidelines 6. Rating the quality of evidence—imprecision. J Clin Epidemiol 64(12):1283–93 https://doi.org/10.1016/j.jclinepi.2011.01.012 Epub 2011 Aug 11. Erratum in: J Clin Epidemiol. 2021 Sep;137:265

Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, Alonso-Coello P, Djulbegovic B, Atkins D, Falck-Ytter Y, Williams JW Jr, Meerpohl J, Norris SL, Akl EA, Schünemann HJ (2011) GRADE guidelines 5 Rating the quality of evidence--publication bias. J Clin Epidemiol 64(12):1277–82 https://doi.org/10.1016/j.jclinepi.2011.01.011

Zheng YX et al (2019) Bushen Yijing Fang reduces fall risk in late postmenopausal women with osteopenia: A randomized double-blind and placebo-controlled trial. Sci Rep 9(1):2089. https://doi.org/10.1038/s41598-018-38335-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao Q et al (2019) Clinical study on Jintiange Capsules combined with Alfacalcidol Soft Capsules in treatment of postmenopausal osteoporosis. Drugs Clin 34(11):3352–3357. https://doi.org/10.7501/j.issn.1674-5515.2019.11.034

Article  Google Scholar 

Wu W et al (2005) Preventive and therapeutic effects of Xianling Gubao capsules for postmenopausal osteoporosis. J Guangzhou Univ Trad Chin Med 22(3):191–193. https://doi.org/10.3969/j.issn.1007-3213.2005.03.008

Article  Google Scholar 

Xu YL et al (2018) Clinical observation on 38 cases of postmenopausal osteoporosis treated with Jinggu Bugu granule. Chin J Gen Pract 16(7):1188–1191. https://doi.org/10.3969/j.issn.1673-8225.2009.37026

Article  Google Scholar 

Yi S et al (2019) Effect of Yijing Tiaoxue method on bone conversion markers in postmenopausal osteoporosis patients. Syst Med 4(24):4–7. https://doi.org/10.19368/j.cnki.2096-1782.2019.24.004

Article  Google Scholar 

Wu ZJ et al. (2020) 温肾固疏汤治疗绝经后胸腰椎骨质疏松性骨折40例临床观察(Clinical observation of 40 cases of postmenopausal thoracolumbar osteoporosis fracture treated by Wen Sheng Gushu decoction). Chin J Ethnomed Ethnopharm 29(6):81–83, 87

Chen WG et al (2019) Clinical study on Erxian decoction combined with PKP in treatment of osteoporotic vertebral compression fractures with postmenopausal osteoporosis. Chin J Inf Trad Chin Med 26(6):14–18. https://doi.org/10.3969/j.issn.1005-5304.2019.06.004

Article  CAS  Google Scholar 

Li CW et al (2014) Effect of the therapeutic methods (TCM) of Reinforcing QI Warming Meridians on bone turnover indicators in patients with postmenopausal osteoporotic hip fracture. J Trad Chin Orthop Traumatol 26(12):887–889

Google Scholar 

Lao RP et al (2012) 补肾健脾活血法对绝经后骨质疏松症患者骨碱性磷酸酶的影响(Effect of Bushen Jianpi Huoxue method on bone alkaline phosphatase in postmenopausal osteoporosis patients. Guangming J Chin Med 27(10):1983–1984

Google Scholar 

Ren Y et al (2017) Effects of Lujiao Zhuanggu Capsules on Reproductive Endocrine Hormone and Bone Metabolism in Patients with Postmenopausal osteoporosis. China Pharm 28(2):212–215. https://doi.org/10.6039/j.issn.1001-0408.2017.02.18

Article  Google Scholar 

Zhou JT et al. (2017) 补肾活血中药治疗绝经后骨质疏松症临床研究 (Clinical Study on the Treatment of Postmenopausal Osteoporosis with Bushen Huoxue Chinese medicine). Zhejiang J Integr Trad Chin West Med 27(5):398–400. https://doi.org/10.13288/j.11-2166/r.2015.09.012

Ye L et al (2018) Effect of Yi Gu Decoction on estrogen, cell factor level in patients with postmenopausal osteoporosis. Lab Med Clin 15(24):3726–3728. https://doi.org/10.3969/j.issn.1672-9455.2018.24.022

Article  CAS  Google Scholar 

Wang XW et al (2018) 补肾活血汤联合钙尔奇治疗绝经后原发性骨质疏松症100例临床观察(Clinical Observation on 100 Cases of Postmenopausal Primary Osteoporosis Treated with Bushen Huoxue Decoction and Calcium). Chin J Ethnomed Ethnopharm 27(24):127–129

Google Scholar 

Zhang L et al (2016) Effect of Bushen Duanxu decoction on postmenopausal osteoporosis and its effect on the level of serum MMP-2. Mod J Integr Trad Chin West Med 25(35):3896–3898. https://doi.org/10.3969/j.issn.1008-8849.2016.35.007 3977

Article  Google Scholar 

Liu BX, Huang CJ, Liang DB (2011) Clinical Control Study on Postmenopausal Osteoporosis Treated with Embedding Thread according to Syndrome Differentiation and Medication. Zhongguo Zhong Xi Yi Jie He Za Zhi 31(10):1349–1354

PubMed  Google Scholar 

Zhang RH et al (2005) A clinical study of Yigu capsule in treating postmenopausal osteoporosis. Chin J Intergr Med 11(2):97–103. https://doi.org/10.1007/BF02836464

Article  CAS  Google Scholar 

Lu XL et al. (2018) 益肾健骨汤治疗原发性骨质疏松症的疗效及对血清ALP, BGP, TRAP, β-CTx的影响 (Effect of Yishen Jiangu decoction on primary osteoporosis and its effect on serum ALP, BGP, TRAP and β-CTx) Guiding. J Trad Chin Med Pharmacol 24(8):119–124 https://doi.org/10.13862/j.cnki.cn43-1446/r.2018.08.038

Lin Z et al (2021) Clinical study on Gushukang capsules combined with alfacalcidol for senile osteoporosis New. Chin Med 53(15):96–99. https://doi.org/10.13457/j.cnki.jncm.2020.15.014